This unique program will provide state-of-the-art approaches to diagnosis and management of colorectal cancer in high risk populations. Patients with inflammatory bowel disease (IBD) are at high risk of developing colon cancer. There has also been an alarming trend of younger individuals developing rectal cancers. Chromoendoscopy provides a new tool for detection of cancer in high risk populations. New endoscopic and surgical approaches are changing diagnosis and management of colorectal cancer. These timely topics grounded in the most recent scientific and clinical guidelines will be covered by leading experts. In addition, case discussions with a multidisciplinary panel of gastroenterologists, surgeons, genetic counselors and pathologists will enable direct application of new knowledge to real-world scenarios. The goal is to provide attendees with tools to improve early identification and prevention of colorectal cancer in high-risk populations.